Cutaneous Diphtheria in France : Observational, Retrospective Study of Patient Characteristics
NCT ID: NCT05798247
Last Updated: 2025-07-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
63 participants
OBSERVATIONAL
2023-04-03
2023-08-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Identification of the Cutaneous Microbiota in Patients With Cutaneous Infection (MICROBIOTA)
NCT03985475
Eschar Investigations in Scrub Typhus
NCT02915861
Surveillance of Community-Associated MRSA
NCT04083092
Evaluation of the Decolonization Rate and Acceptance of a Complete Nasal Decolonization Kit With Povidone Iodine for MRSA Patients
NCT05696132
Risk Factors for Treatment Failure of Scabies in Autochthonous Populations of French Guiana (GUYAGALE)
NCT04931680
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with cutaneous diphteria
The study group consists of all the patients suffering from cutaneous diphtheria in metropolitan France and for which microbiological data were registered by the National Reference Center fo corynebacteria of the diphteriae complex between 2018 and 2022.
Characteristics description
Caregivers who follow the patients of the study group will be contacted to collect these patients clinical and epidemiological characteristics
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Characteristics description
Caregivers who follow the patients of the study group will be contacted to collect these patients clinical and epidemiological characteristics
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient living in metropolitan France
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre d'Epidémiologie et de Santé Publique des Armées
UNKNOWN
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fabien DUTASTA, MD
Role: STUDY_DIRECTOR
SSA
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut Hospitalo-Universitaire de Marseille
Marseille, Bouches-du-Rhône, France
CHU de Dijon
Dijon, Bourgogne-Franche-Comté, France
CHU de Caen
Caen, Calvados, France
Centre Hospitalier de Brive
Brive-la-Gaillarde, Corrèze, France
Centre Hospitalier de Guingamp
Pabu, Côtes d'Armor, France
Centre Hospitalier Sud Francilien
Corbeil-Essonnes, Essonne, France
CHU Bordeaux
Bordeaux, Gironde, France
Hôpital Louis Pasteur (HCC)
Colmar, Haut-Rhin, France
Centre Hospitalier Alpes-Leman CHAL
Contamine-sur-Arve, Haute-Savoie, France
Centre Hospitalier de Briançon
Briançon, Hautes-Alpes, France
Centre Hospitalier de Lourdes
Lourdes, Hautes-Pyrénées, France
Hôpital Ambroise Paré (AP-HP)
Boulogne-Billancourt, Hauts-de-Seine, France
Hôpital Américain de Paris
Neuilly-sur-Seine, Hauts-de-Seine, France
CHU de Montpellier
Montpellier, Hérault, France
CHRU de Tours
Chambray-lès-Tours, Indre-et-Loire, France
Groupement Hospitalier Nord Dauphiné
Bourgoin, Isère, France
CHU de Nantes
Nantes, Loire-Atlantique, France
Centre Hospitalier Régional d'Orléans
Orléans, Loiret, France
Centre Hospitalier de Cahors
Cahors, Lot, France
Centre Hospitalier Cholet
Cholet, Maine-et-Loire, France
Centre Hospitalier de Saint-Lo
Saint-Lô, Manche, France
CHU de Lille
Lille, Nord, France
Centre Hospitalier de Valenciennes
Valenciennes, Nord, France
CHU de Saint-Etienne
Saint-Priest-en-Jarez, Pays de la Loire Region, France
Centre d'endocrinologie
Cabestany, Pyrénées Orientales, France
Hôpital Edouard Herriot (HCL)
Lyon, Rhône, France
Hôpital Croix rousse (HCL)
Lyon, Rhône, France
Centre Hospitalier William Morey
Chalon-sur-Saône, Saône-et-Loire, France
Centre Hospitalier de Mâcon
Mâcon, Saône-et-Loire, France
Hôpital Avicenne Bobigny (AP-HP)
Bobigny, Seine-Saint-Denis, France
CHU d'Amiens
Amiens, Somme, France
Hôpital Nord Franche-Comté
Trévenans, Territoire De Belfort, France
Hôpital Henri Mondor (AP-HP)
Créteil, Val-de-Marne, France
HIA Sainte Anne
Toulon, VAR, France
Centre Hospitalier d'Avignon
Avignon, Vaucluse, France
Centre Hospitalier Départemental de Vendée
La Roche-sur-Yon, Vendée, France
Hôpital Saint Joseph
Paris, , France
Hôpital Saint Louis
Paris, , France
Hôpital Saint Antoine
Paris, , France
Hôpital La Pitié Salpêtrière
Paris, , France
Groupement Hospitalier Diaconesses Croix Saint Simon
Paris, , France
CHU de Toulouse - Hôpital La Grave
Toulouse, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Bernard KA, Pacheco AL, Burdz T, Wiebe D. Increase in detection of Corynebacterium diphtheriae in Canada: 2006-2019. Can Commun Dis Rep. 2019 Nov 7;45(11):296-301. doi: 10.14745/ccdr.v45i11a04. eCollection 2019 Nov 7.
Martini H, Soetens O, Litt D, Fry NK, Detemmerman L, Wybo I, Desombere I, Efstratiou A, Pierard D. Diphtheria in Belgium: 2010-2017. J Med Microbiol. 2019 Oct;68(10):1517-1525. doi: 10.1099/jmm.0.001039.
Jaton L, Kritikos A, Bodenmann P, Greub G, Merz L. [European migrant crisis and reemergence of infections in Switzerland]. Rev Med Suisse. 2016 Apr 13;12(514):749-53. French.
Morgado-Carrasco D, Riquelme-Mc Loughlin C, Fusta-Novell X, Fernandez-Pittol MJ, Bosch J, Mascaro JM Jr. Cutaneous Diphtheria Mimicking Pyoderma Gangrenosum. JAMA Dermatol. 2018 Feb 1;154(2):227-228. doi: 10.1001/jamadermatol.2017.4786. No abstract available.
Pandit N, Yeshwanth M. Cutaneous diphtheria in a child. Int J Dermatol. 1999 Apr;38(4):298-9. doi: 10.1046/j.1365-4362.1999.00658.x. No abstract available.
Wagner KS, White JM, Lucenko I, Mercer D, Crowcroft NS, Neal S, Efstratiou A; Diphtheria Surveillance Network. Diphtheria in the postepidemic period, Europe, 2000-2009. Emerg Infect Dis. 2012 Feb;18(2):217-25. doi: 10.3201/eid1802.110987.
Gower CM, Scobie A, Fry NK, Litt DJ, Cameron JC, Chand MA, Brown CS, Collins S, White JM, Ramsay ME, Amirthalingam G. The changing epidemiology of diphtheria in the United Kingdom, 2009 to 2017. Euro Surveill. 2020 Mar;25(11):1900462. doi: 10.2807/1560-7917.ES.2020.25.11.1900462.
Koopman JS, Campbell J. The role of cutaneous diphtheria infections in a diphtheria epidemic. J Infect Dis. 1975 Mar;131(3):239-44. doi: 10.1093/infdis/131.3.239.
de Benoist AC, White JM, Efstratiou A, Kelly C, Mann G, Nazareth B, Irish CJ, Kumar D, Crowcroft NS. Imported cutaneous diphtheria, United Kingdom. Emerg Infect Dis. 2004 Mar;10(3):511-3. doi: 10.3201/eid1003.030524.
Chene L, Morand JJ, Badell E, Toubiana J, Janvier F, Marthinet H, Suppini JP, Valois A, Texier G, Brisse S, Dutasta F OEDIPE Study Group. Cutaneous diphtheria from 2018 to 2022: an observational, retrospective study of epidemiological, microbiological, clinical, and therapeutic characteristics in metropolitan France. Emerg Microbes Infect. 2024 Dec;13(1):2408324. doi: 10.1080/22221751.2024.2408324. Epub 2024 Sep 30.
Related Links
Access external resources that provide additional context or updates about the study.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-CHITS-013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.